2 H -pyrazolo[3,4- d ]pyrimidin-4-amine derivatives as novel selective fibroblast growth factor receptor 2 (FGFR2) inhibitors
Journal of Enzyme Inhibition and Medicinal Chemistry · 31.12.2026 · 41 (1)
DOI: 10.1080/14756366.2026.2647526 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, online erschienen am 30.03.2026. Verfasst von Pinglian Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Chang-Kung Chuang Institute, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 2, Pyrimidines, Protein Kinase Inhibitors, Pyrazoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Although FGFR2 is a well-validated oncogenic target, no selective FGFR2 inhibitors have been approved for clinical use. In this study, we report the discovery of 2H-pyrazolo[3,4-d]pyrimidin-4-amine derivative as novel, irreversible FGFR2 inhibitors. The optimal compound, PLW559, potently inhibited FGFR2 with an IC50 value of 13.59 nM and demonstrated exceptional selectivity over FGFR1, FGFR3, and FGFR4. Covalent binding to the target was confirmed by mass spectrometry. In cellular models, PLW559 exhibited potent and selective antiproliferative effects against FGFR2-driven cancer cells, effectively suppressed downstream FGFR2 signalling and induced cancer cell apoptosis. Notably, it showed minimal activity in non-FGFR2-dependent cells. This work presents a new class of selective FGFR2 inhibitors based on a novel scaffold, offering promising lead compounds for the development of FGFR2-target therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chang-Kung Chuang Institute, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
- State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.
- KinoTeck Therapeutics Co., Ltd, Guangzhou City, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wu, P., Tian, Z., Shen, W., Xun, Q., Tian, Y., Li, H., Yang, B., Chang, S., Huang, W., Wang, Z., Ding, K., & Ma, D. (2026). 2 H -pyrazolo[3,4- d ]pyrimidin-4-amine derivatives as novel selective fibroblast growth factor receptor 2 (FGFR2) inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 41(1). https://doi.org/10.1080/14756366.2026.2647526
Vancouver
Wu P, Tian Z, Shen W, Xun Q, Tian Y, Li H, et al. 2 H -pyrazolo[3,4- d ]pyrimidin-4-amine derivatives as novel selective fibroblast growth factor receptor 2 (FGFR2) inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 2026;41(1). doi:10.1080/14756366.2026.2647526
BibTeX
@article{Wu2026,
author = {Wu, Pinglian and Tian, Zhaodi and Shen, Weizhong and Xun, Qiuju and Tian, Yuan and Li, Huiqiong and Yang, Bowen and Chang, Shaohua and Huang, Weixue and Wang, Zhen and Ding, Ke and Ma, Dawei},
title = {2 H -pyrazolo[3,4- d ]pyrimidin-4-amine derivatives as novel selective fibroblast growth factor receptor 2 (FGFR2) inhibitors},
journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
year = {2026},
volume = {41},
number = {1},
doi = {10.1080/14756366.2026.2647526}
}
EUVIMED